Telomir Pharmaceuticals, Inc.

TELO

US87975F1049

Pharmaceuticals

Delayed Nasdaq Other stock markets 11:49:24 2024-07-05 am EDT			5-day change	1st Jan Change
3.83 ^USD	+2.13%		-20.37%	0.00%

Jul. 02	Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes	MT
Jul. 01	Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Small Cap Comp Value Index	CI

Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2500 Growth Index

July 30, 2024

Latest news about Telomir Pharmaceuticals, Inc.

Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes	Jul. 02	MT
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Small Cap Comp Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Small Cap Completeness Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2000 Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Microcap Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000 Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2000 Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000E Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2500 Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Microcap Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2500 Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Small Cap Comp Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000E Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000 Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2000 Growth Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2000 Dynamic Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell Microcap Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000E Value Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 2500 Index	Jun. 30	CI
Telomir Pharmaceuticals, Inc.(NasdaqCM:TELO) added to Russell 3000 Index	Jun. 30	CI
Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	May. 30	CI
Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Telomir Pharmaceuticals, Inc. Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C	Apr. 16	CI
Telomir Pharmaceuticals, Inc. Announces Resignation of Christos Nicholoudis, Esq. as the General Counsel and A Member of the Board of Directors	Apr. 12	CI
Telomir Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI

Chart Telomir Pharmaceuticals, Inc.

Duration

Period

More charts

Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acidâs (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
TELOMIR PHARMACEUTICALS, INC.	0.00%	111M
ELI LILLY AND COMPANY	+56.60%	809B
NOVO NORDISK A/S	+39.52%	624B
JOHNSON & JOHNSON	-7.12%	351B
ABBVIE INC.	+7.04%	289B
ASTRAZENECA PLC	+13.74%	240B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+8.32%	166B
PFIZER, INC.	-2.85%	157B